411 related articles for article (PubMed ID: 19602132)
1. Liver fat and lipid oxidation in humans.
Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
[TBL] [Abstract][Full Text] [Related]
2. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
3. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV
J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
[TBL] [Abstract][Full Text] [Related]
4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
7. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
8. Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation.
Perseghin G; Scifo P; Danna M; Battezzati A; Benedini S; Meneghini E; Del Maschio A; Luzi L
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E556-64. PubMed ID: 12169449
[TBL] [Abstract][Full Text] [Related]
9. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
Bugianesi E; Gastaldelli A; Vanni E; Gambino R; Cassader M; Baldi S; Ponti V; Pagano G; Ferrannini E; Rizzetto M
Diabetologia; 2005 Apr; 48(4):634-42. PubMed ID: 15747110
[TBL] [Abstract][Full Text] [Related]
11. Effect of liver fat on insulin clearance.
Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
[TBL] [Abstract][Full Text] [Related]
12. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
13. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
14. Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects.
Matzinger O; Schneiter P; Tappy L
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E125-31. PubMed ID: 11739092
[TBL] [Abstract][Full Text] [Related]
15. Fat oxidation and plasma removal capacity of an intravenous fat emulsion in elderly and young men.
Aberg W; Thörne A; Olivecrona T; Nordenström J
Nutrition; 2006; 22(7-8):738-43. PubMed ID: 16815487
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
Gjedsted J; Gormsen LC; Nielsen S; Schmitz O; Djurhuus CB; Keiding S; Ørskov H; Tønnesen E; Møller N
Acta Physiol (Oxf); 2007 Nov; 191(3):205-16. PubMed ID: 17784905
[TBL] [Abstract][Full Text] [Related]
17. [Reduced insulin effect in subclinical fatty liver].
Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
[TBL] [Abstract][Full Text] [Related]
18. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
19. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
[TBL] [Abstract][Full Text] [Related]
20. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
